Literature DB >> 3919101

In vivo and in vitro studies of the binding of antibody/dsDNA immune complexes to rabbit and guinea pig platelets.

R P Taylor, G Kujala, K Wilson, E Wright, A Harbin.   

Abstract

The in vivo and in vitro binding of prepared antibody/dsDNA immune complexes to rabbit and guinea pig cellular blood components was examined. The in vitro binding in these two nonprimates was almost entirely due to platelets, and required homologous, intact complement; furthermore, no appreciable binding was observed for neutrophils, mononuclear cells, or erythrocytes at normal blood concentrations. The in vivo binding reaction occurred quite rapidly (less than 1 min for maximal binding) and the majority of the injected counts were cleared from the circulation in 3 to 5 min. Over this time period, however, a large fraction of the counts remaining in the circulation also remained bound to the animals' cells (presumably platelets), and this result was most pronounced for complement-fixing immune complexes prepared with high m.w. dsDNA. In vitro studies confirmed that immune complexes prepared with such dsDNA are rather slowly released from the animal platelets in the presence of homologous serum, and this result is in marked contrast to the considerably greater lability of bovine serum albumin/anti-bovine serum albumin immune complexes that are bound to complement receptors on animal and human cells. These observations suggest that the fate of immune-complexed dsDNA in the circulation may be very different from that of free dsDNA, and in the case of nonprimates may involve a platelet-mediated immune complex clearance mechanism analogous to the erythrocyte-mediated immune complex clearance mechanism which is believed to be operative in primates.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919101

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Immune complex processing in C1q-deficient mice.

Authors:  J T Nash; P R Taylor; M Botto; P J Norsworthy; K A Davies; M J Walport
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

2.  Chronic serum sickness glomerulonephritis: removal of glomerular antigen and electron-dense deposits is largely dependent on plasma complement.

Authors:  P N Furness; D R Turner
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

3.  Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes.

Authors:  W Emlen; V Carl; G Burdick
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

4.  Ligation of erythrocyte CR1 induces its clustering in complex with scaffolding protein FAP-1.

Authors:  Ionita Ghiran; Aleksandra M Glodek; Gregory Weaver; Lloyd B Klickstein; Anne Nicholson-Weller
Journal:  Blood       Date:  2008-08-06       Impact factor: 22.113

5.  Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance.

Authors:  P Rumore; B Muralidhar; M Lin; C Lai; C R Steinman
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

6.  Tetanus toxoid-anti-tetanus toxoid complexes: a potential model to study the complement transport system for immune complex in humans.

Authors:  J P Paccaud; G Steiger; A G Sjöholm; P J Spaeth; J A Schifferli
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

7.  In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees.

Authors:  R P Kimberly; J C Edberg; L T Merriam; S B Clarkson; J C Unkeless; R P Taylor
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

8.  Studies in the rat of antibody-sensitized and N-ethylmaleimide-treated erythrocyte clearance by the liver: effects of immune complex infusion and complement activation.

Authors:  N Yousaf; J C Howard; B D Williams
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

Review 9.  Of mice and men: the relevance of the mouse to the study of human SLE.

Authors:  D J Birmingham; B H Rovin; C Y Yu; L A Hebert
Journal:  Immunol Res       Date:  2001       Impact factor: 4.505

10.  Blockade of clearance of immune complexes by an anti-Fc gamma receptor monoclonal antibody.

Authors:  S B Clarkson; R P Kimberly; J E Valinsky; M D Witmer; J B Bussel; R L Nachman; J C Unkeless
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.